| Description |
1 online resource (xv, 99 pages) : illustrations |
| Physical Medium |
polychrome |
| Description |
text file |
| Note |
This report summarizes speaker presentations and discussions from a December 4, 2007 workshop given by the Roundtable on Translating Genomic-Based Research for Health. |
| Bibliography |
Includes bibliographical references (pages 85-88). |
| Contents |
Introduction -- Translation of innovations -- A broad perspective, -- Understanding types of innovation and implications for policy -- Lessons for genomics from other technologies -- Discussion -- Practical incentives and barriers to translation -- Translating medical innovations with appropriate evidence -- Assessing technology for use in health and medicine -- Integrating genetic technology into a health care system -- View from the trenches: challenges and opportunities in personalized medicine -- Discussion -- Translation of genomic technology at the clinical level -- A primary-care provider view of translating genomic innovation -- Introducing a genomic innovation to clinical practice. -- Discussion -- Opportunities and constraints for translation of genomic innovations -- The global perspective -- Finding value in translation of genomic-based research. -- Discussion -- Concluding remarks -- General observations. |
| Summary |
Until fairly recently, genetic information was used primarily in the diagnosis of relatively rare genetic diseases, such as cystic fibrosis and Huntington's Disease, but a transformation in the use of genetic and genomic information is underway. While many predictions have been made that genomics will transform medicine, to date few of these promising discoveries have resulted in actual applications in medicine and health. The Institute of Medicine's Round table on Translating Genomic-Based Research for Health, established in 2007, held its first workshop to address the following questions: are there different pathways by which new scientific findings move from the research setting into health care? If so, what are the implications of those different pathways for genomics? What can we learn from the translation of other new technologies as we seek to understand the translation of genome science into health care? Information obtained from the workshop was then used to further discussion and exploration of the answers to these questions. This book summarizes speaker presentations and discussions. Any conclusions reported should not be construed as reflecting a group consensus; rather they are the statements and opinions of presenters and participants. |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Medical genetics.
|
|
Medical genetics. |
|
Genomics.
|
|
Genomics. |
|
Medical genetics -- Technological innovations.
|
|
Technological innovations. |
|
Genomics -- Technological innovations.
|
|
Genomics. |
|
Diffusion of Innovation. |
|
Genetic Research. |
|
Genetic Techniques. |
|
Genetics, Medical. |
| Genre/Form |
Congress.
|
|
Electronic books.
|
|
Conference papers and proceedings.
|
|
Conference papers and proceedings.
|
| Added Author |
Hernandez, Lyla M.
|
|
Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health.
|
|
Institute of Medicine (U.S.). Board on Health Sciences Policy.
|
| Other Form: |
Print version: Diffusion and use of genomic innovations in health and medicine. Washington, D.C. : National Academies Press, ©2008 0309116767 9780309116763 (DLC) 2008298619 (OCoLC)234146574 |
| ISBN |
9780309116770 (electronic book) |
|
0309116775 (electronic book) |
|
1281767379 |
|
9781281767370 |
|
9780309116763 |
|
0309116767 |
|
